Fig. 2
From: Renal function in β-thalassemia major patients treated with two different iron-chelation regimes
Correlation between uNAG and the amount of iron transfused in prior 10 years in All patients (no correlation found, r = 0.08521, p = 0.6), patients treated with DFX (no correlation found, r = 0.023, P = 0.8949) and in patients treated with DFO+/−DFP – significant positive (r = 0.7, P = 0.02). (DFX) Deferasirox. (DFO) Desferrioxamine. (DFP) Deferiprone